Buy or sell Pear Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Pear Therapeutics Stock

Prescription Digital Therapeutics

Founded

2013

Notable Investors

Novartis

Headquarters

Boston MA, US

Total Funding

$270M

About Pear Therapeutics Stock

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia. 

Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. 

Investors

Funding History

February 2016$22.0M
December 2017$51.0M
December 2018$70.7M
December 2020$38.9M
December 2020$87.5M

Management

Chief Executive Officer

Corey McCann

Chief Financial & Operating Officer

Chris Guiffre

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Pear Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 210K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo